Alan Stitt, Belfast. ‘New therapeutic options for diabetic retinopathy.’ Host: Luminita Paraoan
1:00pm - 2:00pm /
Friday 24th January 2020
/ Venue: William Henry Duncan Apex Building
- 01517949003
- Brenda Smith
- Suitable for: Staff and students
- Admission: Free to staff and students
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Alan Stitt, McCauley Chair of Experimental Ophthalmology, Queen’s University Belfast
‘New therapeutic options for diabetic retinopathy.’
Alan’s research focuses on the pathogenesis of diabetic retinopathy and age-related retinal disease. This work has revealed novel therapeutic avenues, some of which have progressed into Phase II/III clinical trials to prevent neurodegeneration and microvascular recovery in the ischaemic retina. Linked to this regenerative theme, is his research which is seeking to harness the reparative potential of a unique endothelial progenitor-type to re-vascularise the ischaemic retina and repair the early vascular damage that is characteristic of diabetic retinopathy. Alan’s talk will provide an overview of the treatment options for diabetic retinopathy and the possibilities of earlier treatments that prevent progression to sight loss in patients.
Host: Luminita Paraoan
Contact: leifh@liverpool.ac.uk and Louise.Simpson@liverpool.ac.uk
if you would like talk broadcast live to Leahurst or Aintree
Please always sign attendance sheet. All welcome.
Many thanks. Brenda Smith
‘New therapeutic options for diabetic retinopathy.’
Alan’s research focuses on the pathogenesis of diabetic retinopathy and age-related retinal disease. This work has revealed novel therapeutic avenues, some of which have progressed into Phase II/III clinical trials to prevent neurodegeneration and microvascular recovery in the ischaemic retina. Linked to this regenerative theme, is his research which is seeking to harness the reparative potential of a unique endothelial progenitor-type to re-vascularise the ischaemic retina and repair the early vascular damage that is characteristic of diabetic retinopathy. Alan’s talk will provide an overview of the treatment options for diabetic retinopathy and the possibilities of earlier treatments that prevent progression to sight loss in patients.
Host: Luminita Paraoan
Contact: leifh@liverpool.ac.uk and Louise.Simpson@liverpool.ac.uk
if you would like talk broadcast live to Leahurst or Aintree
Please always sign attendance sheet. All welcome.
Many thanks. Brenda Smith